Introduction
Faciogenital dysplasia (FGDY), which is also known as Aarskog-Scott syndrome, is a rare inherited multisystemic developmental disorder described in the early 1970s by Aarskog (1970) and Scott (1971) . The disease phenotype consists of short stature and characteristic facial, skeletal, and urogenital anomalies. Impaired growth is a major manifestation of the disease, and affected males rarely exceed 160 cm in height. Stature is disproportionate and the distal extremities are most severely shortened (Duncan et al., 1977) . Radiographic abnormalities include hypoplastic phalanges and retarded bone maturation (Grier et al., 1983) . A variety of vertebral anomalies, including cervical spina bifida occulta, odontoid hypoplasia, and segmentation anomalies, occur in about half of affected males (Fryns, 1992) . Facial features typically consist of widely spaced eyes, external ear anomalies, and maxillary hypoplasia (Melnick and Shields, 1976) . Urogenital malformations include scrotal anomalies, hypospadius, and kidney hypoplasia (Gorlin et al., 1990) . Based on these phenotypes, it has been suggested that FGDY be considered a multiple congenital anomaly syndrome involving at least two developmental field defects, the skeletal and urogenital systems (Gorlin et al., 1990) .
Pedigree analyses of families segregating FGDY strongly suggested an X-linked recessive pattern of inheritance (Gorlin et al., 1990) . Typically, the phenotype of obligate female heterozygotes was limited to relatively short stature and subtler craniofacial anomalies. Although the observation of male-to-male transmission of an FGDY-like syndrome suggested that FGDY may be genetically heterogeneous (Grier et al., 1983; van deVooren et al., 1983 ) genetic linkage studies confirmed that, in most affected f&hilies, FGDY wasxlinked and mapped tothe pericentric region of the X chromosome (Porteous et al., 1992; Stevenson et al., 1994) . FGDY was also mapped to this region based on the observation of a mother and son who both displayed all of the major characteristics of FGDY in association with a reciprocal X;8 chromosome translocation (Bawle et al., 1984) . Since the overwhelming majority of disease-associated reciprocal translocations have been found to have breakpoints within a candidate gene locus (Tommerup, 1993) it was reasonable to hypothesize that the FGDY-specific breakpoint directly disrupted the disease locus. Glover et al. (1993) recently sublocalized the FGDY X chromosome breakpoint to a region within Xpl 1.21 that was flanked by loci ALAS2 and DXS323. Earlier radiation hybrid mapping experiments indicated that these loci were separated by approximately 350 kb (Gorski et al., 1992) . Together, these results suggested that it would be possible to use a positional cloning strategy to isolate the FGDY gene.
We report here the isolation and characterization of a candidate gene, termed FGD7, for X-linked FGDY. The FGD7 gene maps to the appropriate physical interval and is disrupted by the disease-specific t(X;8) breakpoint. An FGD7 mutation detected by single strand conformation polymorphism (SSCP) analysis cosegregates with the disease in a second affected family. FGDl shows strong homology to Rho/Rat guanine nucleotide exchange factors (GEFs), proteins involved in growth regulation and signal transduction. These results suggest that molecular defects in this gene cause the developmental growth anomalies underlying FGDY.
Results

Isolation of Yeast Artificial Chromosomes
Spanning an FGDY Breakpoint Markers that detect the closest known loci flanking the FGDY X chromosomal breakpoint, ALAS2 and DXS323 (Figure 1 A) , were used to screen a human Xchromosomespecific yeast artificial chromosome (YAC) library. Three clones, including 21G3 and 2904, were found to contain (Gorski et al., 1992) ; the FGDY X;6 translocation breakpoint was mapped to the region between loci ALAS2 and OX5323 (Glover et al., 1993) . Bars indicate the relative X chromosomal content of somatic cell hybrid cell lines C9-5, HPPI, and GM10501 as previously reported (Lafreniere et al., 1991; Gorski et al., 1992) ADULT Fluorescent in situ hybridization studiesshowed that clone 27G3 was nonchimeric and hybridized to the rearranged X and I3 chromosomes and the normal X homolog (data not shown). Together, these results confirmed that clone 27G3 spanned the FGDY t(X;8) breakpoint. The constructed restriction maps of clones 27G3 and 2904 were generally in agreement, suggesting that the two conforming YAC insert segments were colinear with genomic DNA ( Figure 1A ). Long-range restriction analyses tentatively localized the FGDY t(X;8) breakpoint to a 10 kb BssHll fragment (data not shown); this fragment was contained in clone 27G3 and was flanked by two potential CpG islands ( Figure 1A) . A h phage subclone contig of clone 21G3 was constructed (Pasteris et al., 1993) and phage DNA inserts were examined to identify low copy (LC) and evolutionarily conserved sequences. One such fragment was identified from the 10 kb interval, a 5.5 kb EcoRl fragment, LCe5.5 ( Figure  1A) . When hybridized to a filter containing DNA derived from FGDY t(X;8) family members, probe LCe5.5 detected the normal 5.5 kb EcoRl fragment in the unaffected family members GP and GM and in affected member PP and detected two unique fragments, 8.0 and 3.0 kb in size, in affected members PP and CP (Figure 16 ). Only the 3.0 kb fragment was detected in cell line HPPI. The 8.0 and 3.0 kb fragments were detected only in the DNA of the affected family members. The 5.5 kb fragment alone was observed in the DNA of 16 different unrelated individuals; similar results were obtained by using other restriction enzymes (data not shown). Together, these results indicated that probe LCe5.5 spanned the FGDY translocation breakpoint and detected the junctional EcoRl fragments of both the derivative X and the reciprocal derivative 8 chromosome. These results also showed that the 3.0 kb fragment was derived from the FGDY derivativeXchromosome and that, at this level of resolution, no apparent deletion was associated with the translocation.
Isolation of Candidate cDNA Clones ProbeLCe5.5 was used to screen human 16-week-old fetal brain (FB) and fetal craniofacial (FCF) cDNA libraries. We isolated eight independent FCF clones and two distinct FB clones from 2 x 1 O6 clones screened. Of the positive FCF clones, three were found to be identical by restriction mapping and were designated clone pFCF1 .l . This clone was used to rescreen the FCF library and isolate 30 additional clones; these clones were analyzed to construct a cDNA contig ( Figure 1A ). To verify that the isolated cDNA clones spanned the FGDY breakpoint, cDNA subclones derived from the extreme portions of the constructed contig were hybridized to FGDY t(X;8) family member DNA. As shown in Figure 1 B, pFCF1 .l, a probe containing the 5' end of the cDNA, detected a pattern of 5.5 and 3.0 kb fragments that was superimposable to that detected by LCe5.5, including the 3.0 kb fragment detected in HPPI DNA. In contrast, pFBte1 .O, a probe containing the 3' end of the cDNA, detected a 2.5 kb EcoRl fragment that was present in the DNA of FGDY t(X;8) family members and in hybrid cell lines GM10501 and GM06318, but absent in HPPI DNA. These results mapped pFCF1.1 proximal to (and pFBte1 .O distal to) the FGDY breakpoint and confirmed that the cDNA, termed FGD7, was directly disrupted by the FGDY t(X;8) breakpoint. Expression of the FGDl Gene Hybridization of the FGD7 cDNA to a Northern blot containing poly(A)f RNA detected a 4.4 kb transcript in fetal heart, brain, lung, kidney, placenta, and (to alesserextent) liver ( Figure 2A ). A similarly sized transcript was detected in adult heart, brain, lung, skeletal muscle, and (to a lesser extent) pancreas and liver ( Figure 2B ). Several other lessprominent transcripts that may represent alternatively spliced or cross-hybridizing transcripts were observed in placenta and adult brain, lung, and skeletal muscle.
FGD7 cDNA Sequence Analysis Both strands of the composite FGD7 cDNA were sequenced in at least two independent clones over the entire length of the contig. In addition, 90% of the sequence was also confirmed by sequencing cloned genomic DNA (N. G. P. et al., unpublished data). The cDNA was 4266 bp in length and contained a 2883 nt open reading frame (ORF) that was predicted to encode a protein of 961 amino acids with a predicted mass of 107 kDa ( Figure 3 ). The putative initiation codon of this ORF began at nucleotide 731, and the flanking sequences conformed to a translation initiation consensus sequence (Kozak, 1987) . Preliminary data indicated that the first 936 bp of the cDNA was contained in a single exon that mapped proximal to the FGDY t(X;8) breakpoint (data not shown), indicating that the predicted ORF was directly disrupted by the breakpoint.
The sequence 5' of the proposed initiating methionine FGDY; products of the normal father, the obligate carrier mother, and the two affected FGDY brothers (TS and CS) are in lanes 1, 4, 2, and 3, respectively.
Lane 5 contains the products of a normal male; lanes 6-10 contain the products of unrelated FGDY patients; and lanes 11 and 12 contain products derived from cDNA and genomic DNA clones, respectively. (6) Sequence analysis of the products amplified with primer pair E7-2 from a normal male and the FGDY-affected male CS. Compared with the normal sequence, the product of CS had an additional guanine residue, indicated by a star, inserted at nucleotide 2122.
codon had stop codons in all three ORFs. An upstream and putatively nonfunctional initiation codon was found at nucleotide 490 ( Figure 3A ). Several observations suggested that this initiation codon was an unlikely translation start site: the potential ORF associated with this ATG codon was predicted to encode a low complexity 37 amino acid peptide, two in-frame termination codons were found between the first and second potential initiation codons, and this codon was predicted to be an unlikely site of translation initiation (Kozak, 1987 (Porteous et al., 1992; Stevenson et al., 1994) . In an FGDY family with two affected male siblings and an obligate carrier female, asimilar band shift was seen in all three individuals for the ET-7 primer pair ( Figure 4A ). The double-stranded product of each of the FGDY male siblings appeared to be slightly larger than the normal product. The DNAof the carrier female appeared to yield three products (a normally sized product, a mutant product, and a larger and presumably heteroduplex product), findings consistent with her known heterozygote status. The single-stranded products of all three individuals demonstrated anomalous gel mobility ( Figure 4A ). Compared with the normal product, sequence analysis showed that the aberrantly sized product contained an insertional mutation with an additional guanine residue present at nucleotide 2122 (Figure4B); the resultingframeshih mutation was predicted to cause premature translational termination at residue 469. In contrast, an analysis of 82 normal X chromosomes with the same primer set failed to yield an abnormal product.
Predicted Amino Acid Sequence of FGDl Comparison of the predicted FGDl protein sequence with other sequences in the data bases indicated that the FGD7 gene encoded a putative FiholRacGEF. RholRacGEFs form afamilyof cytoplasmic proteins that activate the Raslike family of Rho and Rat proteins by exchanging bound GDP for free GTP (Boguski and McCormick, 1993) . Like theother RholRacGEFfamily members, the FGD7-derived amino acid sequence contained three structurally conserved regions (SC&) spanning 180 amino acids ( Figure  5A ). Sequence alignment of the predicted FGDl protein with other RholRacGEF proteins illustrated the remarkable similarity between the predicted FGDl protein and other members of the GEF subfamily over the 180 residue region of functional significance. Among RholRacGEFs, the predicted FGDl protein showed the greatest similarity (p = 1.4e-6) to the ect2 protein (Miki et al., 1993) . However, the predicted FGDl protein showed strong similarity to several other family members, including RasGRF (p = 1.3e-6) (Shou et al., 1992) Dbl (p = 8.8e-5) (Ron et al., 1991) , and Bcr(p = 5.3e-5) (Lifshitz et al., 1988 ). An examination of the sequence immediately 3' of the conserved RholRacGEFdomain predicted thatthe FGDl protein also contained a pleckstrin homology motif (data not shown), a feature common to other RholRacGEF family members (Musacchio et al., 1993) . Comparison of the derived FGDl protein sequence with other sequences in the data bases suggested that it contained two additional structural motifs (see Figure 38) . The 3' region of the sequence was predicted to encode a 50 amino acid cysteine-rich region that contained a zinc finger-like structural motif. Although this region showed the greatest similarity with two proteins of unknown function, the Caenorhabditis elegans protein ZK632.12 (p = 7.le-12) and the Saccharomyces cerevisiae protein Fabl (p = 1.9e-5) this region showed some degree of similarity to the zinc finger-like regions of both the Vacl protein (Weisman and Wickner, 1992) and the diacylglycerollphorbol diester-binding regulatory domain of protein kinase CT (PKCy) (Quest et al., 1994) . The sequence alignment of the predicted FGDl protein with the other zinc finger-like proteins is shown in Figure 5B . This alignment illustrated that the predicted FGDl zinc finger-like structural motif, C-X&-X1&-X,-C-X&-X&XI&-X~-C (single letter code; X denoting variable residues), was identical to that found in the ZK632.12 and Fabl protein sequences and similar to the PKCr motif. The remarkably strong conservation of this region among proteins derived from organisms as distantly related as humans, nematodes, and yeast inferred that this region was functionally significant and suggested that this region contained a cysteine-rich zinc finger-like domain thatwas similarto, but distinct from, thatcontained in PKCy.
An analysis of the predicted FGDl protein showed that the 5' region was remarkably proline-rich and that proline constituted 22% of the first 250 amino acid residues. Since proline-rich regions have been shown to contain Src homology 3 (SHS)-binding domains (Egan et al., 1993; Rozakis-Adcock et al., 1993) , the 5' portion of the derived FGDl protein sequence was compared with other sequences known to contain SH3-binding sites. As shown in Figure 5C , this comparison identified two partially overlapping segments of the predicted FGDl sequence that exhibited strong similarity to the functionally significant regionsof several proteins with demonstrated SH3 binding activity, including the Abl SH8binding proteins 3BPl and 3BP2 (Ren et al., 1993) and the RasGEF mSos2 (Egan et al., 1993; Rozakis-Adcock et al., 1993) . The derived consensus sequence for the alignment was identical to that proposed by Ren et al. (1993) 
Discussion
A number of lines of evidence strongly suggest that FGD7 is the gene responsible for X-linked FGDY. First, it maps to Xpl1.21, the region known to contain a gene responsible for FGDY. Second, the fGD7 locus is directly disrupted by a translocation breakpoint in a family in which the disease is segregating. Third, an insertional mutation, predicted to result in a severely abbreviated and nonfunctional FGDI protein, segregates with the FGDY phenotype in an affected family. Fourth, fGD7 mRNA is expressed in most tissues, including FCF bones, a finding consistent with the disease phenotype. Finally, the derived FGDl amino acid sequence predicts a protein with RholRacGEF activity. In addition, this predicted sequence contains two other potential structural motifs: a cysteine-rich zinc finger-like structural domain that is related to the regulatory domain of PKCy and two putative SH9binding domains. The remarkable similarity of FGD7 to several protooncogenes involved in the regulation of growth-related signal transduction (i.e., Dbl, Bcr, ect2, and VW), further suggests that the FGDl protein is responsible for the altered pattern of embryonic development observed in FGDY.
Our assertion that FGDl is a putative RholRacGEF is based upon the results of our comparative sequence analysis. The predicted FGDl protein sequence contains a 180 amino acid structural motif that is significantly similar to other RholRacGEF family members, including Cdc24, Dbl, and ect2. Several lines of evidence indicate that members of this family do indeed represent RholRacGEFs. In yeast, CDC24 has been shown to regulate CDC42Sc (Bender and Pringle, 1989) , whose human homolog, CDC42Hs, encodes a Rho-related GTP-binding protein involved in the regulation of cytoskeletal organization (Shinjo et al., 1990) . Dbl has been shown specifically to stimulate guanine exchange activity for human CDC42Hs and RhoA (Hart et al., 1991 (Hart et al., , 1994 . Although ect2 has not been found to stimulate exchange activity for CDC42Mm, it has been shown specifically to bind to several Rhorelated proteins, including Racl, RhoA, and RhoC (Miki et al., 1993) . Furthermore, the structurally conserved 180 amino acid motif identified in FGDl represents the only common sequence contained in all RholRacGEF protein family members (Boguski and McCormick, 1993) . It has recently been shown that the transforming and GEF activities of the Dbl protein are carried in a 238 amino acid peptide that contains this 180 residue domain (Hart et al., 1994) . These results indicate that this domain is sufficient and specific for RholRacGEF activity and suggest that FGDl is a family member. However, the recent demonstration that Vav, a putative RholRacGEF family member, stimulates the exchange of GTP for ~21"" but not for Rhorelated proteins (Gulbins et al., 1993) , suggests that this motif may not be an absolute predictor of GEF specificity (Boguski and McCormick, 1993) .
The results of our comparative sequence analysis also indicate that, like other RholRacGEFs, the predicted FGDI sequence contains two additional structural domains that may either modify or regulate its activity or do both: a putative SHS-binding domain and a cysteine-rich zinc finger-like domain. SH3 domains have been shown specifically to bind to short (9-l 0 amino acid) proline-rich structurally conserved motifs contained in a variety of proteins, including the RasGEF SOS (Li et al., 1993; Ren et al., 1993; Rozakis-Adcock et al., 1993) . Like the putative FGDl SHS-binding domains, the SOS-binding motifs are quitesimilartothosecontained in 3BP1,3BP2, andformin, domains with demonstrated Abl SH3 domain specificity (Egan et al., 1993; Li et al., 1993; Rozakis-Adcock et al., 1993) . Recently, it has been shown that a protein composed entirely of an SH2 domain flanked by two SH3 domains, GrbP (homologous to Sem-5 in C. elegans and Drk in Drosophila), selectively binds the proline-rich motifs of the SOS protein to form a link in a signal transduction pathyJay that functionally ties tyrosine kinase receptors to Ras (B&day and Downward, 1993; Egan et al., 1993; Li et al., 1993; Rozakis-Adcock et al., 1993) . Among the identified Ras and RholRacGEF family members, SOS is unique in containing an SH3-or GrbP-binding domain (Boguski and McCormick, 1993) . The identification of a putative prolinerich SHB-binding domain in the predicted FGDl protein implies that, like SOS, the location, activity, or both of the FGDl protein may be modified by Abl-and GrbPlike proteins.
Like the product of the proto-oncogene RholRacGEF member Vav (Coppola et al., 1991) , the predicted FGDl sequence also contains a putative cysteine-rich zinc finger-like domain that is related to but distinct from the diacylglycerol and phorbol diester-binding regulatory domain of PKCy (Quest et al., 1994) . The zinc finger-like domain of theVav protein has been shown to be functionallysignificant; mutations of the conserved cysteine residues were found to -abolish the transforming activity of the proteins (Coppola et al., 1991) . Similar putative regulatory domains have been identified in a variety of Ras-associated proteins, including the product of the raf proto-oncogene, the RholRac GTPase-activating protein n-chimerin, and diacylglycerol kinase (Liscovitch and Cantley, 1994) . The observation that the predicted FGDl sequence contains a putative zinc finger-like domain suggests that the FGDl protein may interact with lipid second messenger molecules. Therefore, it is possible that the FGDl protein may interact with the components of multiple signal transduction pathways.
Since both of the identified FGDY mutations predict the total absence of FGDl protein in affected individuals, our findings predict that the constitutional loss of FGDl Rho/ RacGEF activity in humans results in the clinical FGDY phenotype of disproportionately short stature and craniofacial, skeletal, and urogenital anomalies. However, our results do not suggest a specific mechanism as to how the absence of the FGDl protein would result in the observed developmental anomalies. In S. cerevisiae, Schizosaccharomyces pombe, Drosophila melanogaster, and C. elegans, the genetic loss of GEF function has effects similar to a loss of the associated Ras protein (see Boguski and McCormick, 1993) . In mammals, Rho protein family members consist of at least eight distinct proteins (RhoA, RhoB, RhoC, Racl, Race, TCl 0, CDC42Hs1, and CDC42Hs2) (Downward, 1992; Boguski and McCormick, 1993) . Rho-like proteins have been shown to be involved in the regulation of the architecture of the actin cytoskeleton , yeast bud site assembly and cell polarity (Drubin, 1991) , and the NADPH oxidase system in phagocytes (Abo et al., 1991) . Therefore, the study of FGDl may provide important information regarding the roles that Rho-and Rat-like proteins play in signal transduction and mammalian development. Furthermore, if, as we expect, FGDl interacts with other signal transduction components, genes that encode FGDlassociated proteins may be responsible for other similar inherited developmental disorders. Such anticipated interactions may provide an explanation for the previous reports of FGDY genetic heterogeneity.
Several Ras-associated proteins have been found to be responsible for human genetic diseases. Neurofibromin (NFl), the human protein defective in neurofibromatosis type 1, contains a RasGAP domain homologous to the catalytic domains of pl20-GAP, IRA, and IRA2 (Buchberg et al., 1990) . As recently reported by the European Chromosome 16 Tuberous Sclerosis Consortium (1993) tuberin, the gene responsible for the form of tuberous sclerosis mapped to chromosome 16 (TSC2), has some homology to the GAP3 protein. The gene responsible for choroderemia, a retinal degeneration syndrome, is similar to a Rab geranylgeranyl transferase (Seabra et al., 1993) . However, because FGDl is a member of the Rho/RacGEF family directly implicated in causing an inherited human disease, the study of FGDl , in the context of its normal function and regulation, will provide important information regarding the roles that Ras-like GEFs play in signal transduction and mammalian development. The demonstrated strong homology of other Ras-associated family members implies that it may be possible and valuable to study homologs of the FGDl protein in other animal systems. Furthermore, studies of the features of FGDl that resemble those of the transforming RholRacGEF family members may aid in the understanding of oncogene regulation and the events leading to transformation. Indeed, it will be interesting to determine whether FGDl is involved in human neoplastic disease.
Experimental Procedures
Somatic Cell Hybrids and Lymphoblastoid Cell Lines Epstein-Barr virus-transformed lymphoblastoid cell lines were derived from a female patient with FGDY and an X;8 translocation (PP), her similarly affected son (CP), and her normal parents (GM and GP) (Bawle et al., 1984) . HPPI is a human-hamster hybrid cell line that contains the translocated X chromosome t(X;8)(pll.21;11.21) derived from PP (Glover et al., 1993) . C9-5 contains the translocated X chromosome t(X;S)(pl1.21;q34.3) derived from a female with incontinentia pigmenti type 1 (Gorski et al., 1989 (Gorski et al., , 1992 (Lee et al., 1992) . DNA markers that detect ALA.92 and DXS323 have been described (Gorski et al., 1992) . High molecular weight yeast DNA was prepared and analyzed as described (Gorski et al., 1992) . Restriction maps were obtained by hybridizing YAC vector-specific and insert-specific probes to blots of fully and partially digested PFGE-fractionated YAC DNA. YAC insert end clones were recovered by inverse PCR (Arveiler and Porteous, 1991) confirmed by restriction analysis, and mapped to Xpll.21 by using fragments as probe to perform somatic cell hybrid and YAC DNA hybridizations.
Standard
and PFGE Hybridization Analysis DNA was isolated, digested, transferred to Hybond-N nylon membranes (Amersham), and hybridized as described (Gorski et al., 1992) . Hybridizations were performed for 18-24 hr at 85'C, and membranes were washed to a final stringency of 0.1 x SSC, 0.1% SDS at 85OC for at least IO min (Gorski et al., 1992) . Plasmid DNA was prepared by standard techniques; prior to use as probe, DNA fragments were recovered from agarose gel by electroelution (Sambrook et al., 1989) or by adhesion to a silica matrix (810 101).
cDNA Isolation and Characterization ZAPII human 1 g-week-old FB and FCF cDNA libraries were screened by standard methods (Sambrook et al., 1989) . Bluescript KS(+) plasmid clones containing cDNA inserts were isolated by in vivo excision as per recommendations of the supplier (Stratagene). Fetal and adult tissue poly(A)+ RNA Northern blots were obtained from Clonetech and hybridizations were performed as described (Sambrook et al., 1989 
Mutatlon
Analysis Portions of the FGDI cDNA for which exonlintron boundaries were known were PCR amplified and analyzed by SSCP (Orita et al., 1989) . Primer pairs were used as follows: E7-7, GGACCGCTATCCACGCATTGGAGA and TCAAAGTTCTTCACATACTCACC, which amplify cDNA sequences from bases 2072 to 2154; E4-7, ATACCCTGCTTCCATGTGTGTCC and GAAACAGGCAGCGGGAGGCCTCA, which amplify cDNA sequences from bases 1388 to 1529; E4-2, TGAGGCCTCCCGCTGCCTGTTTC and GGCAACAGGCACACTAGCCAGGG, which amplify cDNA sequences from bases 1507 to 1899; E4-3, CCCTGGCTAGTGTGCCTGTTGCC and CTCTCGGTGAACACAGGTCAGT, which amplify cDNA sequences from bases 1877 to 1830. Exon amplifications were performed in 50 ul volumes containing 50 mM KCI, 10 mM Tris (pH 8.0), 10 mglml BSA, 1.5 mM MgCl*, 200 pM each of dATP, dGTP, and dlTP, 20 uM dCTP, 1 uCi of [a-3*P]dCTP, 100 ng of genomic DNA, 0.5 uM primers, and 2.5 U of AmpliTaq (Perkin-Elmer Cetus). Amplifications were performed in a DNA Thermal Cycler 480 (Perkin-Elmer Cetus) with 35 cycles of 1 min of denaturation at 94OC, 1 min of annealing at 55'C-59°C and 2-4 min of extension at 72OC.
For SSCP analysis, 2 PI of a PCR was mixed with an equal volume of stop solution (United States Biochemicals), boiled for 5 min, cooled on ice for 2 min, and loaded on a 8% polyacrylamide gel containing 5% glycerol and 0.5 x TBE buffer. Samples were electrophoresed at both 4OC for 4-8 hr at 20 W and overnight at room temperature at 1-5 W of constant power. PCR products were sequenced as described (Casanova et al., 1990 ) with slight modifications. Amplification was performed by substituting primer pair E7-2 (GGACCGCTATCCACGCATTGGAGAand ATGCGCTGCACAGGCTCCAGCAT), which amplifies cDNA sequences from bases 2072 to 2289, and 180 uM dCTP for the 1 nCi of [aJ2P]dCTP.
Product was purified by adhesion to silica matrix (610 101) and resuspended in 21 nl of water: 7 91 of the product (approximately 200 ng) was sequenced as above by using primer CTGCACCTCATGGATGATGACTT (bases 2227-2205), added in 20 M excess. Prior to sequencing, the reaction was boiled for 2 min and
